Artificial Intelligence: Reshaping AMD Management
Provider: Mivision
Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616
Activity Outline
The integration of artificial intelligence (AI) into
age-related macular degeneration management heralds a new era of personalised
care and precision medicine. With its ability to predict disease progression,
identify biomarkers, and assist in treatment decision-making, AI offers a
powerful tool to enhance visual outcomes for AMD patients.
word count: 3,043
Learning Objectives
- Understand the role artificial intelligence can play in detection and management of AMD
- Be aware of the accuracy that can be achieved when using AI to screen for AMD
- Realise the logistical and financial benefits of AI screening
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| Artificial Intelligence: Reshaping AMD Management |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.5 |